<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JCO Oncol Pract</journal-id><journal-id journal-id-type="iso-abbrev">JCO Oncol Pract</journal-id><journal-id journal-id-type="pmc-domain-id">3790</journal-id><journal-id journal-id-type="pmc-domain">jcoop</journal-id><journal-id journal-id-type="publisher-id">OP</journal-id><journal-title-group><journal-title>JCO Oncology Practice</journal-title></journal-title-group><issn pub-type="ppub">2688-1527</issn><issn pub-type="epub">2688-1535</issn><publisher><publisher-name>American Society of Clinical Oncology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10166398</article-id><article-id pub-id-type="pmcid-ver">PMC10166398.1</article-id><article-id pub-id-type="pmcaid">10166398</article-id><article-id pub-id-type="pmcaiid">10166398</article-id><article-id pub-id-type="pmid">36516366</article-id><article-id pub-id-type="doi">10.1200/OP.22.00273</article-id><article-id pub-id-type="publisher-id">OP.22.00273</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>SPECIAL SERIES: TEAMS IN CANCER CARE</subject><subj-group><subject>Original Contributions</subject></subj-group></subj-group></article-categories><title-group><article-title>Developing a Collaborative, Team-Based Smoking Cessation Treatment Program in an Outpatient Oncology Setting</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2123-0879</contrib-id><name name-style="western"><surname>Cooper</surname><given-names initials="SL">Sara L.</given-names></name><degrees>PhD, MSPH</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kovar</surname><given-names initials="V">Vladka</given-names></name><degrees>MD, MPH</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3167-0384</contrib-id><name name-style="western"><surname>Levinson</surname><given-names initials="AH">Arnold H.</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><aff id="aff1"><label><sup>1</sup></label>Department of Community and Behavioral Health, University of Colorado School of Public Health, Aurora, CO</aff><aff id="aff2"><label><sup>2</sup></label>University of Colorado Cancer Center, Aurora, CO</aff></contrib-group><author-notes><corresp id="cor1">Sara L. Cooper, PhD, MSPH, University of Colorado School of Public Health, 13001 E 17th Pl B119, Aurora, CO 80045; e-mail: <email>sara.cooper@cuanschutz.edu</email>.</corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>14</day><month>12</month><year>2022</year></pub-date><volume>19</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">427198</issue-id><fpage>e115</fpage><lpage>e124</lpage><history><date date-type="accepted"><day>26</day><month>10</month><year>2022</year></date><date date-type="received"><day>22</day><month>4</month><year>2022</year></date><date date-type="rev-recd"><day>19</day><month>10</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-01-01 00:25:09.840"><day>01</day><month>01</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2022 by American Society of Clinical Oncology</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>American Society of Clinical Oncology</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="op-19-e115.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="op-19-e115.pdf"/><abstract><title>PURPOSE:</title><p>Because clinical specialists often lack time and training to address secondary health issues such as smoking cessation, the National Cancer Institute Cancer Center Cessation Initiative (C3I) has mobilized cancer centers to develop systems for treating patients' tobacco dependence.</p><sec><title>METHODS:</title><p>One university-based cancer center was able to develop a program that formalized smoking treatment using a collaborative, multidisciplinary care team with overlapping expertise in cancer care, medication management, and tobacco cessation. Program planners delivered tobacco cessation services in the outpatient setting by automating identification of eligible patients using a tobacco registry in the electronic health records, directly involving oncology pharmacists in medication oversight, using dedicated tobacco treatment specialists to provide cessation services, and engaging oncologists through active communications protocols. Evaluators used Practical Robust Implementation and Sustainability Model as the guiding framework for a qualitative assessment of program development and implementation. Evaluators also measured provider satisfaction and utilization of services, program reach, and smoking cessation outcomes 6 months post enrollment.</p></sec><sec><title>RESULTS:</title><p>During the evaluation period (July 1, 2018-September 30, 2019), the smoking cessation program engaged 96% of eligible patients (n = 214 of 223 eligible); 82% of those enrolled in the program (n = 183). At 6-month follow-up, 29.1% of enrolled patients self-reported 30-day point prevalence abstinence (n = 53) and 34.9% (n = 64) reported 7-day point prevalence abstinence (intent-to-treat rates).</p></sec><sec><title>CONCLUSION:</title><p>Using a team-based approach that leverages individual expertise and interprofessional collaboration to provide patient-centered treatment, a smoking cessation program can identify and treat eligible patients in specialty clinics.</p></sec></abstract><counts><fig-count count="5"/><table-count count="0"/><equation-count count="0"/><ref-count count="24"/><page-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>STATUS</meta-name><meta-value>ONLINE-ONLY</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>